BOTOX ONE
Live / Registered — Registered (as of 12 Dec 2023)
What this means for you
Registered since 12 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97115552
- Registration number
- 7243677
- Mark type
- Stylized text
- Filed
- 09 Nov 2021
- Published for opposition
- 04 Oct 2022
- Registered
- 12 Dec 2023
Goods and services
- Class 035 — Advertising and business services: Promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via print, audio, video, digital, on-line medium, and electronic mail; Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; distribution of samples for trial purposes in the field of neurology, dermatology and urology
- Class 044 — Medical, beauty and agricultural services: Providing resources in the nature of health information for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the fields of neurology and urology
Owner
- Allergan, Inc., North Chicago, IL, US
- Allergan, Inc., North Chicago, IL, US
- Allergan, Inc., Irvine, CA, US
Prosecution history
- 12 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2023 — EXAMINER'S AMENDMENT ENTERED
- 08 Nov 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Nov 2023 — EXAMINERS AMENDMENT E-MAILED
- 08 Nov 2023 — SU-EXAMINER'S AMENDMENT WRITTEN
- 01 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Nov 2023 — NON-FINAL ACTION E-MAILED
- 01 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 16 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Apr 2023 — USE AMENDMENT FILED
- 10 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Apr 2023 — TEAS STATEMENT OF USE RECEIVED